JnJ seeks USFDA nod of Stelara for pediatric Crohn's disease Ruchika Sharma18 Jun 2025 11:58 AM ISTHorsham: Johnson & Johnson is seeking the U.S. Food and Drug Administration (FDA) approval for the expansion of STELARA (ustekinumab) for the...
JnJ elects JPMorganChase President Daniel Pinto to its Board of Directors Ruchika Sharma11 Jun 2025 4:07 PM ISTNew Brunswick: Johnson & Johnson has elected JPMorganChase's President Daniel Pinto to its Board of Directors.Pinto is a prominent business...
Icotrokinra results show significant skin clearance in patients with difficult to treat scalp, genital psoriasis: JnJ Ruchika Sharma12 May 2025 10:30 AM ISTSpring House: Johnson & Johnson has announced new data from the Phase 3 ICONIC-TOTAL study investigating icotrokinra (JNJ-2113), the...
JnJ Imaavy gets USFDA okay for generalized myasthenia gravis Ruchika Sharma1 May 2025 1:15 PM ISTSpring House: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for IMAAVY (nipocalimab-aahu), a human...
JnJ closes Intra-Cellular Therapies acquisition Ruchika Sharma3 April 2025 10:30 AM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is...
JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease Ruchika Sharma19 March 2025 1:30 PM ISTSpring House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for...
JnJ MedTech gets clearance for MONARCH QUEST for enhanced Robotic-Assisted Bronchoscopy Ruchika Sharma14 March 2025 10:00 AM ISTSanta Clara: Johnson & Johnson MedTech has announced U.S. 510(k) regulatory clearance for MONARCH QUEST, the latest advancement in MONARCH...
JnJ to discontinue Phase 3 VENTURA development program evaluating aticaprant for major depressive disorder Ruchika Sharma7 March 2025 1:30 PM ISTTitusville: Johnson & Johnson has announced the decision to discontinue the Phase 3 VENTURA development program evaluating aticaprant as an...
JnJ names Darren Snellgrove as Vice President, Investor Relations Ruchika Sharma5 March 2025 12:51 PM ISTNew Brunswick: Johnson & Johnson has announced the appointment of Darren Snellgrove to Vice President of Investor Relations. Jessica Moore,...
JnJ to resume US VARIPULSE cases Ruchika Sharma20 Feb 2025 9:30 AM ISTNew Brunswick: Johnson & Johnson will resume the limited market release of VARIPULSE in the United States after a comprehensive...
Johnson & Johnson MedTech launches CEREGLIDE 92 Catheter System for Acute ischemic stroke Ruchika Sharma13 Feb 2025 4:54 PM ISTIrvine: Johnson & Johnson MedTech, an emerging leader in neurovascular care, has announced the launch of the CEREGLIDE 92 Catheter System, a...
